Carvalho JF

No ORCID on file · 4 papers in corpus · active 2019-2021
2021
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deab152

Study questionWhat is the cumulative delivery rate (CDR) per aspiration IVF/ICSI cycle in low-prognosis patients as defined by the Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria?Summary answerThe C…

2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.630550

ObjectiveTo estimate the prevalence of low-prognosis patients according to the POSEIDON criteria using real-world data.DesignMulticenter population-based cohort study.SettingsFertility clinics in Brazil, Turkey, and Vietnam.PatientsInfertil…

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00099

The POSEIDON group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) has introduced "the ability to retrieve the number of oocytes needed to achieve at least one euploid embryo for transfer" as an intermediate marker o…

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00917

This multicenter study evaluated the reliability of the recently published ART calculator for predicting the minimum number of metaphase II (MII) oocytes (MIImin) to obtain at least one euploid blastocyst in patients undergoing in vitro fer…